{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:30:45Z","timestamp":1793302245667,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:00:00Z","timestamp":1411689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0145-1","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T05:11:32Z","timestamp":1411621892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Two years\u2019 experience with denosumab for children with Osteogenesis imperfecta type VI"],"prefix":"10.1186","volume":"9","author":[{"given":"Heike","family":"Hoyer-Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Netzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Koerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Schoenau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Semler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"key":"145_CR1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH: Osteogenesis imperfecta. Lancet. 2004, 363: 1377-1385. 10.1016\/S0140-6736(04)16051-0.","journal-title":"Lancet"},{"key":"145_CR2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R: Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998, 339: 947-952. 10.1056\/NEJM199810013391402.","journal-title":"N Engl J Med"},{"key":"145_CR3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","volume":"20","author":"D Gatti","year":"2005","unstructured":"Gatti D, Antoniazzi F, Prizzi R, Braga V, Rossini M, Tato L, Viapiana O, Adami S: Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res. 2005, 20: 758-763. 10.1359\/JBMR.041232.","journal-title":"J Bone Miner Res"},{"key":"145_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","volume":"17","author":"FH Glorieux","year":"2002","unstructured":"Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R: Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 2002, 17: 30-38. 10.1359\/jbmr.2002.17.1.30.","journal-title":"J Bone Miner Res"},{"key":"145_CR5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.bone.2006.10.010","volume":"40","author":"C Land","year":"2007","unstructured":"Land C, Rauch F, Travers R, Glorieux FH: Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment. Bone. 2007, 40: 638-644. 10.1016\/j.bone.2006.10.010.","journal-title":"Bone"},{"key":"145_CR6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","volume":"88","author":"J Becker","year":"2011","unstructured":"Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K, de Vries P, Wirth B, Schoenau E, Wollnik B, Veltman JA, Hoischen A, Netzer C: Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2011, 88: 362-371. 10.1016\/j.ajhg.2011.01.015.","journal-title":"Am J Hum Genet"},{"key":"145_CR7","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/jbmr.487","volume":"26","author":"EP Homan","year":"2011","unstructured":"Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B: Mutations in SERPINF1 cause Osteogenesis imperfecta Type VI. J Bone Miner Res. 2011, 26: 2798-2803. 10.1002\/jbmr.487.","journal-title":"J Bone Miner Res"},{"key":"145_CR8","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1210\/jc.2012-1827","volume":"97","author":"F Rauch","year":"2012","unstructured":"Rauch F, Husseini A, Roughley P, Glorieux FH, Moffatt P: Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI. J Clin Endocrinol Metab. 2012, 97: E1550-1556. 10.1210\/jc.2012-1827.","journal-title":"J Clin Endocrinol Metab"},{"key":"145_CR9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbrc.2009.11.139","volume":"391","author":"T Akiyama","year":"2009","unstructured":"Akiyama T, Dass CR, Shinoda Y, Kawano H, Tanaka S, Choong PF: PEDF regulates osteoclasts via osteoprotegerin and RANKL. Biochem Biophys Res Commun. 2009, 391: 789-794. 10.1016\/j.bbrc.2009.11.139.","journal-title":"Biochem Biophys Res Commun"},{"key":"145_CR10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C: Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009, 361: 756-765. 10.1056\/NEJMoa0809493.","journal-title":"N Engl J Med"},{"key":"145_CR11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","volume":"14","author":"S Chawla","year":"2013","unstructured":"Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, Kroep J, Grimer R, Reichardt P, Rutkowski P, Schuetze S, Skubitz K, Staddon A, Thomas D, Qian Y, Jacobs I: Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol. 2013, 14: 901-908. 10.1016\/S1470-2045(13)70277-8.","journal-title":"Lancet Oncol"},{"key":"145_CR12","first-page":"183","volume":"12","author":"O Semler","year":"2012","unstructured":"Semler O, Netzer C, Hoyer-Kuhn H, Becker J, Eysel P, Schoenau E: First use of the RANKL antibody denosumab in Osteogenesis Imperfecta Type VI. J Musculoskelet Neuronal Interact. 2012, 12: 183-188.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"145_CR13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"MR McClung","year":"2006","unstructured":"McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Bekker PJ: Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006, 354: 821-831. 10.1056\/NEJMoa044459.","journal-title":"N Engl J Med"},{"key":"145_CR14","volume-title":"Pediatric Reference Data for Male and Female Total Body and Spine BMD and BMC","author":"W Wacker","year":"2011","unstructured":"Wacker W, Barden H: Pediatric Reference Data for Male and Female Total Body and Spine BMD and BMC. 2011, Presented at: International Society of Clinical Densitometry, Dallas, TX"},{"key":"145_CR15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/clinchem\/48.2.315","volume":"48","author":"F Rauch","year":"2002","unstructured":"Rauch F, Georg M, Stabrey A, Neu C, Blum WF, Remer T, Manz F, Schoenau E: Collagen markers deoxypyridinoline and hydroxylysine glycosides: pediatric reference data and use for growth prediction in growth hormone-deficient children. Clin Chem. 2002, 48: 315-322.","journal-title":"Clin Chem"},{"key":"145_CR16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1055\/s-0032-1311244","volume":"184","author":"F Koerber","year":"2012","unstructured":"Koerber F, Schulze Uphoff U, Koerber S, Schonau E, Maintz D, Semler O: Introduction of a new standardized assessment score of spine morphology in osteogenesis imperfecta. Rofo. 2012, 184: 719-725. 10.1055\/s-0032-1311244.","journal-title":"Rofo"},{"key":"145_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000331128","volume":"76","author":"O Semler","year":"2011","unstructured":"Semler O, Beccard R, Palmisano D, Demant A, Fricke O, Schoenau E, Koerber F: Reshaping of vertebrae during treatment with neridronate or pamidronate in children with osteogenesis imperfecta. Horm Res Paediatr. 2011, 76: 321-327. 10.1159\/000331128.","journal-title":"Horm Res Paediatr"},{"key":"145_CR18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1469-8749.1989.tb04003.x","volume":"31","author":"DJ Russell","year":"1989","unstructured":"Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S, Jarvis S: The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol. 1989, 31: 341-352. 10.1111\/j.1469-8749.1989.tb04003.x.","journal-title":"Dev Med Child Neurol"},{"key":"145_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00002060-200301000-00006","volume":"82","author":"HL Cintas","year":"2003","unstructured":"Cintas HL, Siegel KL, Furst GP, Gerber LH: Brief assessment of motor function: reliability and concurrent validity of the Gross Motor Scale. Am J Phys Med Rehabil. 2003, 82: 33-41. 10.1097\/00002060-200301000-00006.","journal-title":"Am J Phys Med Rehabil"},{"key":"145_CR20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","volume":"25","author":"DL Kendler","year":"2010","unstructured":"Kendler DL, Roux C, Benhamou CL, Brown JP, Lillestol M, Siddhanti S, Man HS, San Martin J, Bone HG: Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res. 2010, 25: 72-81. 10.1359\/jbmr.090716.","journal-title":"J Bone Miner Res"},{"key":"145_CR21","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMc1206193","volume":"367","author":"R Shroff","year":"2012","unstructured":"Shroff R, Beringer O, Rao K, Hofbauer LC, Schulz A: Denosumab for post-transplantation hypercalcemia in osteopetrosis. N Engl J Med. 2012, 367: 1766-1767. 10.1056\/NEJMc1206193.","journal-title":"N Engl J Med"},{"key":"145_CR22","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2013-1143","volume":"98","author":"C Grasemann","year":"2013","unstructured":"Grasemann C, Schundeln MM, Hovel M, Schweiger B, Bergmann C, Herrmann R, Wieczorek D, Zabel B, Wieland R, Hauffa BP: Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease. J Clin Endocrinol Metab. 2013, 98: 3121-3126. 10.1210\/jc.2013-1143.","journal-title":"J Clin Endocrinol Metab"},{"key":"145_CR23","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","volume":"27","author":"A Boyce","year":"2012","unstructured":"Boyce A, Chong W, Yao J, Gafni R, Kelly M, Chamberlain C, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu J, Farley F, Molinolo A, Bhattacharyya N, Collins M: Denosumab treatment for fibrous dysplasia. J Bone Miner Res. 2012, 27: 1462-1470. 10.1002\/jbmr.1603.","journal-title":"J Bone Miner Res"},{"key":"145_CR24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","volume":"19","author":"PJ Bekker","year":"2004","unstructured":"Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes GB, Dunstan CR, DePaoli AM: A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res. 2004, 19: 1059-1066. 10.1359\/JBMR.040305.","journal-title":"J Bone Miner Res"},{"key":"145_CR25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","volume":"349","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S: Bisphosphonate-induced osteopetrosis. N Engl J Med. 2003, 349: 457-463. 10.1056\/NEJMoa023110.","journal-title":"N Engl J Med"},{"key":"145_CR26","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1200\/JCO.2012.46.4255","volume":"31","author":"NA Karras","year":"2013","unstructured":"Karras NA, Polgreen LE, Ogilvie C, Manivel JC, Skubitz KM, Lipsitz E: Denosumab treatment of metastatic giant-cell tumor of bone in a 10-year-old girl. J Clin Oncol. 2013, 31: e200-202. 10.1200\/JCO.2012.46.4255.","journal-title":"J Clin Oncol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0145-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0145-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0145-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T18:58:10Z","timestamp":1598295490000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0145-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["145"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0145-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718890672.793509198","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]},"article-number":"145"}}